Lung Nodule Management And Lung Cancer Screening In Patients With Abnormal Ct-Scan
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Jacksonville, Florida: 25-003895
Sponsor Protocol Number: 25-003895
About this study
The purpose of this study is to assess the current rate of adherence to incidental lung nodule management and lung cancer screening guidelines in at-risk lung cancer patients identified from chart review.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
Adults (≥ 18 years old) with incidental lung nodules detected during CT imaging (chest, abdomen, coronary calcium score) OR patients that meet the USPSTF lung cancer screening criteria: adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years.
Index imaging done between 01/01/2023 and 01/01/2024
Provide consent for follow-up.
Exclusion Criteria:
Patients who do not fulfill the inclusion criteria.
Patients who do not or cannot provide consent, including but not limited to inability to complete study procedures or questionnaires due to cognitive or language barriers.
Patients without identifiable follow-up recommendations based on imaging findings.
Patients who had a diagnosis of lung cancer within 5 years before the identification of the nodule.
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 4/09/2025. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
Contact |
Jacksonville, Fla.
Mayo Clinic principal investigator Bryan Husta, M.D. |
Contact us for the latest status |
Contact information:
Cancer Center Clinical Trials Referral Office
(855) 776-0015
|
More information
Publications
Publications are currently not available